In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Penumbra (PEN – Research Report), with a price target of ...

BTIG analyst Ryan Zimmerman maintained a Hold rating on Tactile Systems Technology (TCMD – Research Report) yesterday. The company’s shares ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025.

BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February ...

Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...

On Wednesday, BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

Oncocyte will host one-on-one meetings with interested investors. Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule.

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note issued to investors on Tuesday, January 28th. BTIG Research analyst C.

announced today that it will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, on Wednesday, February 12th. Rohit Ramchandani, CFO ...